Suven Pharmaceuticals’ (Suven’s) Q1FY22-23 revenue was up by 28% y-o-y (year-on-year) to Rs339 crore, aided by growth in pharma and specialty chemicals CDMO (contract development and manufacturing organisation) segment.
Market Ahead: Ahead of Market: 12 things that will decide stock action on Tuesday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Ahead of Market: 12 things that will decide stock action on Thursday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Ahead of Market: 12 things that will decide stock action on Thursday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Ahead of Market: 12 things that will decide stock action on Tuesday
SECTIONS
Share
Synopsis
Nimish Shah of Waterfield Advisors said, a correction of up to 10 per cent from Nifty50’s peak value of 15,200 would be a good support level.
iStock
Analysts said it was testing of the 14,200 level that brought buying on Nifty50 at lows.
Related
NSE
Explore Now
NEW DELHI: Nifty opened gap down and traded with deep cuts in the initial session, as the benchmarks bucked the global trend due to a spike in Covid 2.0 cases in India and imposition of curfew in the national capital and few other places. However, Nifty made a comeback due to the buying in dips approach in the market and formed a green Hammer like candle for the day.